Europe Eubiotics Market Size & Forecast Analysis to 2028

Europe Eubiotics Market Size, Share & Industry Trends Analysis Report By Product (Probiotics, Organic Acids, Phytogenic, Prebiotics, and Enzymes), By Application, By Form, By End-use, By Country and Growth Forecast, 2022 - 2028

Published Date: May-2022 | Number of Pages: 96 | Format: PDF | Report ID: KBV-18172

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Eubiotics Market, by Product
1.4.2 Europe Eubiotics Market, by Application
1.4.3 Europe Eubiotics Market, by Form
1.4.4 Europe Eubiotics Market, by End-use
1.4.5 Europe Eubiotics Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Eubiotics Market

Chapter 4. Europe Eubiotics Market by Product
4.1 Europe Probiotics Market by Country
4.2 Europe Organic Acids Market by Country
4.3 Europe Phytogenic Market by Country
4.4 Europe Prebiotics Market by Country
4.5 Europe Enzymes Market by Country

Chapter 5. Europe Eubiotics Market by Application
5.1 Europe Gut Health Market by Country
5.2 Europe Immunity Market by Country
5.3 Europe Yield Market by Country
5.4 Europe Others Market by Country

Chapter 6. Europe Eubiotics Market by Form
6.1 Europe Solid Market by Country
6.2 Europe Liquid Market by Country

Chapter 7. Europe Eubiotics Market by End-use
7.1 Europe Poultry Feed Market by Country
7.2 Europe Swine Feed Market by Country
7.3 Europe Cattle Feed Market by Country
7.4 Europe Aquatic Feed Market by Country
7.5 Europe Others Market by Country

Chapter 8. Europe Eubiotics Market by Country
8.1 Germany Eubiotics Market
8.1.1 Germany Eubiotics Market by Product
8.1.2 Germany Eubiotics Market by Application
8.1.3 Germany Eubiotics Market by Form
8.1.4 Germany Eubiotics Market by End-use
8.2 UK Eubiotics Market
8.2.1 UK Eubiotics Market by Product
8.2.2 UK Eubiotics Market by Application
8.2.3 UK Eubiotics Market by Form
8.2.4 UK Eubiotics Market by End-use
8.3 France Eubiotics Market
8.3.1 France Eubiotics Market by Product
8.3.2 France Eubiotics Market by Application
8.3.3 France Eubiotics Market by Form
8.3.4 France Eubiotics Market by End-use
8.4 Russia Eubiotics Market
8.4.1 Russia Eubiotics Market by Product
8.4.2 Russia Eubiotics Market by Application
8.4.3 Russia Eubiotics Market by Form
8.4.4 Russia Eubiotics Market by End-use
8.5 Spain Eubiotics Market
8.5.1 Spain Eubiotics Market by Product
8.5.2 Spain Eubiotics Market by Application
8.5.3 Spain Eubiotics Market by Form
8.5.4 Spain Eubiotics Market by End-use
8.6 Italy Eubiotics Market
8.6.1 Italy Eubiotics Market by Product
8.6.2 Italy Eubiotics Market by Application
8.6.3 Italy Eubiotics Market by Form
8.6.4 Italy Eubiotics Market by End-use
8.7 Rest of Europe Eubiotics Market
8.7.1 Rest of Europe Eubiotics Market by Product
8.7.2 Rest of Europe Eubiotics Market by Application
8.7.3 Rest of Europe Eubiotics Market by Form
8.7.4 Rest of Europe Eubiotics Market by End-use

Chapter 9. Company Profiles
9.1 Koninklijke DSM N.V.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Acquisitions and Mergers:
9.1.5.3 Product Launches and Product Expansions:
9.2 Novozymes A/S
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 BASF SE
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.4 DuPont de Nemours, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.5 Chr. Hansen Holding A/S
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 Lallemand, Inc.
9.6.1 Company Overview
9.6.2 Recent strategies and developments:
9.6.2.1 Partnerships, Collaborations, and Agreements:
9.7 Lesaffre Group
9.7.1 Company Overview
9.7.2 Recent strategies and developments:
9.7.2.1 Partnerships, Collaborations, and Agreements:
9.8 Kemin Industries, Inc.
9.8.1 Company Overview
9.8.2 Recent strategies and developments:
9.8.2.1 Product Launches and Product Expansions:
9.9 Cargill Corporation
9.9.1 Company Overview
9.9.2 Recent strategies and developments:
9.9.2.1 Product Launches and Product Expansions:
9.10. Calpis Co., Ltd. (Asahi Group Holdings, Ltd.)
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental Analysis
9.10.4 Recent strategies and developments:
9.10.4.1 Approvals and Trials:

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities